The LITE Study: The first transfeminine-specific HIV study in the U.S.
The just launched LITE Study (Leading Innovation for Transgender Women's Health and Empowerment) is the first cohort study of transgender women and transfeminine people in the United States. This project is an exciting new NIH-supported research study that will enroll and reimburse 1,100 transgender women across five US cities (Boston, New York, Baltimore-Washington DC, Atlanta and Miami).
This is a cohort study, which means we will check-in with transgender women participants approximately every 3 months for up to 2 years, with incentives given at each check-in. The study focuses on sexual health and HIV in order to learn about engagement in HIV prevention and treatment; however, we will also be collecting data on a wide range of health and social topics. This project is a partnership between Johns Hopkins Bloomberg School of Public Health, Boston Children's Hospital, Fenway Health, Harvard University T.H. Chan School of Public Health, Callen-Lorde Community Health Center, University of Miami, Emory University and Grady Memorial Hospital, and Whitman Walker Health.
To learn more about the study or how to enroll, please visit the study's website: https://www.litestudy.org/.
Please feel free to share this with individuals who may be interested in enrolling.
|
